Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
CALL
Ferguson
FERG
$48B
| $1.34M | ﹤0.01% |
+6,000
| New | +$1.43M |
|
3202
Microvast
MVST
$341M
| $1.33M | ﹤0.01% |
475,068
+87,247
| +22% | +$365K |
|
3203
Limbach Holdings
LMB
$527M
| $1.33M | ﹤0.01% |
17,068
+1,263
| +8% | +$104K |
|
3204
CALL
ProPetro Holding
PUMP
$1.42B
| $1.33M | ﹤0.01% |
+139,700
| New | +$1.21M |
|
|
NUTX
3205
Nutex Health
NUTX
$1.28B
| $1.33M | ﹤0.01% |
8,063
+3,155
| +64% | +$418K |
|
3206
Lincoln Educational Services
LINC
$955M
| $1.32M | ﹤0.01% |
54,852
+11,818
| +27% | +$258K |
|
3207
Ironwood Pharmaceuticals
IRWD
$674M
| $1.32M | ﹤0.01% |
392,904
+95,586
| +32% | +$248K |
|
|
INVX
3208
Innovex International
INVX
$2.15B
| $1.32M | ﹤0.01% |
60,458
+5,640
| +10% | +$118K |
|
3209
Monopar Therapeutics
MNPR
$741M
| $1.32M | ﹤0.01% |
20,245
+5,163
| +34% | +$422K |
|
3210
Birkenstock
BIRK
$7.54B
| $1.32M | ﹤0.01% |
32,313
+31,677
| +4,981% | +$1.34M |
|
3211
Caledonia Mining Corp
CMCL
$439M
| $1.32M | ﹤0.01% |
50,473
+13,178
| +35% | +$387K |
|
3212
CALL
Biogen
BIIB
$31.1B
| $1.32M | ﹤0.01% |
7,500
| – | – |
|
|
AGNT
3213
AGNT Inc
AGNT
$752M
| $1.32M | ﹤0.01% |
145,594
+11,909
| +9% | +$126K |
|
|
ATXS
3214
DELISTED
Astria Therapeutics
ATXS
| $1.31M | ﹤0.01% |
100,427
-6,682
| -6% | -$79.8K |
|
|
SAFE
3215
Safehold
SAFE
$1.1B
| $1.31M | ﹤0.01% |
95,682
+6,291
| +7% | +$89.4K |
|
3216
Energy Recovery
ERII
$399M
| $1.31M | ﹤0.01% |
97,060
+6,292
| +7% | +$95.4K |
|
3217
Malibu Boats
MBUU
$573M
| $1.31M | ﹤0.01% |
46,413
+2,692
| +6% | +$78.1K |
|
3218
Dream Finders Homes
DFH
$1.35B
| $1.3M | ﹤0.01% |
76,161
+14,554
| +24% | +$298K |
|
3219
Idaho Strategic Resources
IDR
$500M
| $1.3M | ﹤0.01% |
32,313
+4,102
| +15% | +$157K |
|
3220
Integra LifeSciences
IART
$1.42B
| $1.3M | ﹤0.01% |
104,564
+10,101
| +11% | +$134K |
|
3221
American Public Education
APEI
$828M
| $1.3M | ﹤0.01% |
34,348
-554
| -2% | -$19.8K |
|
3222
PUT
Zillow
Z
$8.08B
| $1.3M | ﹤0.01% |
19,000
| – | – |
|
3223
First Watch Restaurant Group
FWRG
$800M
| $1.3M | ﹤0.01% |
85,916
-15,577
| -15% | -$263K |
|
3224
Butterfly Network
BFLY
$2.36B
| $1.3M | ﹤0.01% |
340,825
+65,792
| +24% | +$179K |
|
3225
Orthofix Medical
OFIX
$415M
| $1.29M | ﹤0.01% |
85,227
-50,250
| -37% | -$767K |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.